Kangmei Pharma | 600518 - 贷款资金

金融业

CNY

CNY 13.31B

现金及等价物

CNY 1.23B

CNY 841.45M

CNY 6.8B

CNY 5.38B

CNY 173.71M

CNY -12.72M

CNY -12.72M

6.37K

EPS每股收益

CNY 0

股本和储备

CNY 7.31B

CNY 238.34M

债务利息支出

CNY 1.82M

CNY 2.44M

CNY 68.57M

CNY 17.33B

CNY -16.56M

CNY 1.09B

CNY -10.94M

普通股股本

CNY 13.83B

1.11K

CNY -14.01M

CNY 1.08B

销售和管理费用

CNY 237.06M

CNY 2.38B

贸易债权人

CNY 2.46B

应收帐款人

CNY 2.92B

	贷款资金	更改		日
Akebia Therapeutics	USD 36.39M		11.85M	2026-03
Alaunos Therapeutics	USD 4.47M		5.85M	2022-06
Avita Medical	AUD 42.24M		1.25M	2024-12
Cspc Pharmaceutical	CNY 180.69M		21.94M	2025-12
Dianthus Therapeutics	USD 0		0	2024-12
Genomma Lab Internacional	MXN 4.73B		67.16M	2026-03
Hypermarcas	BRL 7.92B		189.66M	2026-03
Ionis Pharmaceuticals	USD 1.91B		9M	2026-03
IQVIA Holdings	USD 13.99B		105M	2026-03
Jiangsu Hengrui	CNY 37.1M		6.2M	2026-03
Kangmei Pharma	CNY 68.57M		9.87M	2026-03
Moderna	USD 603M		7M	2026-03
Organon & Co	USD 8.55B		75M	2026-03
Revvity	USD 2.63B		836K	2026-03
Sh Fosun Pharma	CNY 15.95B		562.19M	2026-03
Tectonic Therapeutic	USD 17K		26K	2026-03
Viatris	USD 12.41B		67.1M	2026-03
Wuxi Apptec	CNY 1.82B		455.56M	2026-03
Xeris Pharmaceuticals	USD 221.22M		889K	2026-03
Zz Pientze Pharmaceu	CNY 182.29M		4.27M	2026-03